Transaction · 0001610717-26-000392

Saxonov Serge

Saxonov Serge, CEO, reported an open-market or private sale at 10x Genomics, Inc. involving 18545.000000 shares for an estimated $1168774.52. Reported holdings after the transaction were 1085835.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
TXG10x Genomics, Inc.
Filing timeAug 26
Trade dateAug 24, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

TXG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TXG since 2026-08-26Filed 9 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000392
Class A Common Stock
Transaction date
Aug 24, 2026
Filed Aug 26, 2026, 08:46 PM · 2d delay
Shares
18.5k sh
$6.30k per share
Estimated value
-$116M
Computed from shares × price
Holdings after
1.08M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertake…

  3. F3

    The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

  4. F4

    The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

  5. F5

    The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.

Original filing · 0001610717-26-000392
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TXG